Tag: End of Phase 2 Meeting
May 9, 2018
ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update
ARCA biopharma (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported... May 9, 2018
Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
Kura Oncology (Nasdaq:KURA) a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today reported first quarter... March 13, 2018
Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results
Kura Oncology (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today provided a regulatory... February 26, 2018
Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results
Endocyte (NASDAQ:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, provided an update on its corporate strategy and...
January 10, 2018
Biotech Showcase Conference: Notes from the Floor, Day Two
Miss the Biotech Showcase Conference in San Fransisco? Don't worry, the Investing News Network was there on the floor of... December 4, 2017
Oncolytics Biotech Will Present at Upcoming Conference
Oncolytics Biotech announced Dr. Matt Coffey, their president and CEO will be presenting an update on pelareorep in a clinical... November 8, 2017